Home › Funds › Avidity Partners Management LP › CATX
Avidity Partners Management LP position in CATX
PERSPECTIVE THERAPEUTICS INC · Health Care
Avidity Partners Management LP reported holding 6,299,999 shares of CATX (PERSPECTIVE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$21.5M, representing 3.44% of its reported portfolio and ranking #6 among its reported holdings. Avidity Partners Management LP has disclosed CATX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Avidity Partners Management LP's CATX position evolved
Avidity Partners Management LP first disclosed a stake in CATX in Q2 2024 at 3,037,668 shares (US$30.3M). The position peaked in Q3 2024 at 3,444,002 shares, worth US$46.0M. Across 9 filings, Avidity Partners Management LP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 6,299,999 shares valued at US$21.5M — an increase of 250,000 shares quarter over quarter.. Notable position changes include a 61% increase in Q3 2025 (shares fell 20% over the following quarter), a 88% increase in Q1 2026 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 3.04M | $30.29M | New |
| Q3 2024 | 3.44M | $45.98M | Add |
| Q4 2024 | 2.69M | $8.60M | Reduce |
| Q1 2025 | 2.20M | $4.68M | Reduce |
| Q2 2025 | 1.86M | $6.39M | Reduce |
| Q3 2025 | 2.99M | $10.27M | Add |
| Q4 2025 | 3.21M | $8.83M | Add |
| Q1 2026 | 6.05M | $25.23M | Add |
| Q2 2026 | 6.30M | $21.48M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CATX and 13F data
CATX (PERSPECTIVE THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in CATX — the largest reported positions include TCG Crossover Management, LLC (US$27.0M), Commodore Capital LP (US$21.6M), Affinity Asset Advisors, LLC (US$14.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CATX
- TCG Crossover Management, LLC 7.92M sh · $26.99M · Q2 2026
- Commodore Capital LP 6.34M sh · $21.61M · Q2 2026
- Affinity Asset Advisors, LLC 4.21M sh · $14.37M · Q2 2026
- Spruce Street Capital LP 3.69M sh · $12.60M · Q2 2026
- Nicholson Wealth Management Group, LLC 1.62M sh · $5.52M · Q2 2026
- Yu Fan 1.06M sh · $3.60M · Q2 2026
- Ally Bridge Group (NY) LLC 743.96K sh · $2.54M · Q2 2026
More on Avidity Partners Management LP
FAQ
How long has Avidity Partners Management LP held CATX?
Avidity Partners Management LP has disclosed CATX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is Avidity Partners Management LP's current position in CATX?
As of Q2 2026, Avidity Partners Management LP holds 6.30M shares of CATX (PERSPECTIVE THERAPEUTICS INC), valued at $21.48M, representing 3.44% of its reported portfolio and ranking #6.
Has Avidity Partners Management LP been buying or selling CATX?
In the latest 13F filing (Q2 2026), Avidity Partners Management LP increased its position in CATX. The position peaked in Q3 2024 at 3.44M shares.
Which other funds hold CATX?
Other major institutional holders of CATX include TCG Crossover Management, LLC, Commodore Capital LP, Affinity Asset Advisors, LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.